期刊文献+

p53与MDM2基因多态性和东北女性乳腺癌发病风险的相关性研究 被引量:6

The Effects of MDM2 SNP309 and p53 Arg72 Pro on the Breast Cancer Risk in Northeast Chinese Women
下载PDF
导出
摘要 目的肿瘤抑制基因p53及其细胞内负性调控因子MDM2参与了细胞内多种通路,p53基因第72位密码子(Arg72Pro)与MDM2基因309位点(T309G)多态性与多种肿瘤相关。本研究旨在探讨p53基因Arg72Pro、MDM2基因T309G单核苷酸多态性(SNPs)与中国东北女性人群乳腺癌易感性及其与各临床病理参数的相关性。方法用Taqman荧光探针结合实时定量聚合酶链反应检测305例乳腺癌患者和345例健康女性的p53 Arg72Pro和MDM2 T309G多态性。结果 p53基因Arg72Pro GC、GG、GC/GG基因型及G等位基因与乳腺癌易感性密切相关。MDM2 T309G TT基因型及T等位基因与乳腺癌发病风险增高密切相关。浸润性导管癌患者携带p53 Arg72Pro GC/GG基因型的分布频率明显增高(P=0.007)。ER阳性表达的患者携带MDM2T309G TT基因型的分布频率亦明显提高(P=0.009)。结论 p53 Arg72Pro G等位基因、MDM2 T309G T等位基因与乳腺癌发病风险增高相关;p53 Arg72Pro多态性与乳腺癌病理类型、MDM2 T309G与ER阳性表达状态相关联。 Objective The tumor suppressor gene p53 and its negative regulator murine double minute 2 (MDM2) are involved in multiple cellu- lar pathways. Two potentially functional single nueleotide polymorphisms (SNPs) MDM2 T309G and p53 Arg72Pm have been extensively investi- gated to be associated with several tumors. The aim of this study is to investigate the effects of MDM2 T309G and p53 Arg72Pro on the breast cancer risk in Northeast Chinese women. Methods MDM2 T309G and p53 Arg72Pro was examined by Taqman fluorescent probes and quantitative poly- merase chain reaction ( Real-time PCR) in 305 cases of female breast cancer patients and 345 cased of healthy women in Northeast China. Results The results demonstrated that the p53 Arg72Pro GC, GG, GC/GG genotype or G allele associated with increased risk for developing breast cancer. Moreover, MDM2 T309G TT genotype and T allele were associated with significantly increased risk for breast cancer. The distribution frequency of 1953 Arg72Pro GC/GG genotype was higher in invasive ductal carcinoma patients (P = 0.007 ). In addition, the frequency of MDM2 T309G Tr geno- type was higher in the patients with ER positive status(P= 0.009). Conclusion The polymorphisms of p53 Arg72Pro and MDM2T309G associat- ed with the susceptibility of breast cancer. The p53 Arg72Pro variants are related with the type of tumor; meanwhile, MDM2 T309G variants are rele- vant to the ER status of breast cancer patients.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2014年第3期205-208,共4页 Journal of China Medical University
基金 国家自然科学基金(80121886 81341063) 辽宁省科学技术计划(2012225002)
关键词 乳腺癌 P53 MDM2 单核苷酸多态性 breast cancer p53 MDM2 single nucleotide polymorphism
  • 相关文献

参考文献12

  • 1Damin AP, Frazzon AP, Damin DC, et al. Evidence for an associa- tion of TP53 codon 72 polymorphism with breast cancer risk [J]. Cancer Detect Prey, 2006,30 (6) : 523-529. 被引量:1
  • 2Gochhait S, Bukhari SI, Bairwa N, et al. Implication of BRCA2 - 26G>A 5' untranslated region polymorphism in susceptibility to spo- radic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism [ J 1. Breast Cancer Res, 2007,9 (5) : R71. 被引量:1
  • 3Wang X, Jiang X. Mdm2 and MdmX partner to regulate p53 IJl. FEBS Lett,2012,586(10) : 1390-1396. 被引量:1
  • 4Wang X. P53 regulation: teamwork between RING domains of Mdm2 and MdmX [J]. Cell Cycle,2011,10 (24) :4225-4229. 被引量:1
  • 5Bond GL, Hu W, Levine A. A single nucleotide polymorphism in the MDM2 gene : from a molecular and cellular explanation to clinical ef- fect [ J ]. Cancer Res, 2005,65 ( 13 ), 5481-5484. 被引量:1
  • 6Akkiprik M, Sonmez O, Gulluoglu BM, et al. Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer J]. Pathol Oncol Res, 2009,15 (3) : 359-368. 被引量:1
  • 7Hou J, Jiang Y, Tang W, et al. p53 codon 72 polymorphism and breast cancer risk: A meta-analysis [J]. Exp Ther Med, 2013, 5 (5) : 1397-1402. 被引量:1
  • 8Tommiska J, Eerola H, Heinonen M, et al. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival [J]. Clin Cancer Res, 2005,11 (14) : 5098-5103. 被引量:1
  • 9Lum SS, Chua HW, Li H, et al. MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population [J]. Carcinogenesis, 2008, 29(4) : 754-761. 被引量:1
  • 10Millikan RC, Heard K, Winkel S, et al. No association between the MDM2-309T/G promoter polymorphism and breast cancer in Afri- can-Americans or Whites [ J ]. Cancer Epidemiol Biomarkers Prey, 2006,15( 1 ) : 175-177. 被引量:1

二级参考文献11

  • 1Bond GL, Hu W, Bond EE, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans[J]. Cell, 2004, 119(5): 591-602. 被引量:1
  • 2Freedman DA, Levine AJ. Regulation of the p53 protein by the MDM2 oncoprotein-thirty-eighth G.H.A. Clowes Memorial Award Lecture[J]. Cancer Res, 1999, 59(1): 1-7. 被引量:1
  • 3Ma H, Hu Z, Zhai X, et al. Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population[I]. Cancer Lett, 2006, 240(2): 261-267. 被引量:1
  • 4Schrnidt MK, Reincke S, Broeks A, et al. Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium[J]. Cancer Res, 2007, 67(19): 9584-9590. 被引量:1
  • 5Millikan RC, Heard K, Winkel S, et al. No association between the MDM2-309 T/G promoter polymorphism and breast cancer in African-Americans or Whites[]]. Cancer Epidemiol Biomarkers Prey, 2006, 15(1): 175-177. 被引量:1
  • 6Lum SS, Chua HW, Li H, et al. MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population[J].Carcinogenesis, 2008, 29(4): 754-761. 被引量:1
  • 7Sun YF, Leu .JD, Chen SM, et al. Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer[J]. BMc Cancer, 2009, 9:13. 被引量:1
  • 8Singh V, Rastogi N, Mathur N, et al. Association of polymorphism in MDM2 and p53 genes with breast cancer risk in Indian women[J]. Ann Epidemiol, 2008, 18(1): 48-57. 被引量:1
  • 9Ueda M, Yamamoto M, Nunobiki O, et al. Murine double-minute 2 homolog single nudeodde polymorphism 309 and the risk of gynecologic cancer[J]. Hum Cell, 2009, 22(2): 49-54. 被引量:1
  • 10Hori M, ShimazakiJ, Inagawa S, et al. Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer [J]. Breast Cancer Res Treat, 2002, 71(1): 77-83. 被引量:1

共引文献6

同被引文献51

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部